1. Home
  2. BBU vs VERA Comparison

BBU vs VERA Comparison

Compare BBU & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brookfield Business Partners L.P. Limited Partnership Units

BBU

Brookfield Business Partners L.P. Limited Partnership Units

HOLD

Current Price

$31.46

Market Cap

3.1B

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$42.26

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBU
VERA
Founded
2016
2016
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.2B
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
BBU
VERA
Price
$31.46
$42.26
Analyst Decision
Buy
Strong Buy
Analyst Count
5
10
Target Price
$39.40
$81.30
AVG Volume (30 Days)
48.7K
1.2M
Earning Date
05-01-2026
05-05-2026
Dividend Yield
0.79%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$472.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.91
$18.76
52 Week High
$37.75
$56.05

Technical Indicators

Market Signals
Indicator
BBU
VERA
Relative Strength Index (RSI) 44.87 51.88
Support Level $29.90 $40.87
Resistance Level $36.93 $42.77
Average True Range (ATR) 1.38 2.34
MACD 0.23 0.40
Stochastic Oscillator 46.92 45.16

Price Performance

Historical Comparison
BBU
VERA

About BBU Brookfield Business Partners L.P. Limited Partnership Units

Brookfield Business Partners LP is a business services and industrials company. It focused on operating businesses that are either low-cost producers and benefit from high barriers to entry. The company's operating segment includes Business services; Infrastructure services; Industrials and Corporate and other. It generates maximum revenue from the Business Services segment. Geographically operates in USA, Europe, Australia, Brazil, Canada, UK, Mexico and Other, majority of revenue is from UK.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: